HOOKIPA Pharma Inc.

Ownership Transactions Reported by 20 Insiders

Symbol
HOOK on Nasdaq
Industry
Pharmaceutical Preparations
Location
350 Fifth Avenue, 72 Nd Floor, Suite 7240, New York, NY

There are no Buy or Sell transactions made by insiders since 9/17/2023

HOOKIPA Pharma Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Gilead Sciences, Inc. 10%+ Owner $13.6M Dec 20, 2023
Malte Peters Chief Executive Officer, Director $78.8K Jul 22, 2024
Jorn Aldag Chief Executive Officer, Director $52.2K Apr 15, 2024
Mary Theresa Coelho EVP and CFO, Director $50.7K Jul 22, 2024
Reinhard Kandera Chief Financial Officer, Director $31.2K Apr 15, 2024
Katia Schlienger Chief Medical Officer $943 Apr 14, 2023
Klaus Orlinger Chief Scientific Officer Apr 15, 2024
Timothy P. Reilly Director Jun 17, 2024
Christine D. Baker Chief Operating Officer Apr 14, 2023
Graziano Seghezzi Director Jun 1, 2021
Michael Aaron Kelly Director Jun 30, 2022
Julie O'Neill Director Jun 17, 2024
Jan van de Winkel Director Jun 17, 2024
Sean A. Cassidy Director Jul 22, 2024
Christoph Lengauer Director Jun 1, 2021
Mark Winderlich Chief Development Officer Apr 15, 2024
Jean-Charles Soria Director Jun 1, 2021
David Ross Kaufman Director Jun 17, 2024
Igor Matushansky Chief Medical Officer Jun 30, 2022
Roman Necina Chief Operations Officer Apr 15, 2024

Recent Insider Transactions by Companies or Individuals for HOOKIPA Pharma Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.